| PRD_000427 | Name: | FIV PROTEASE INHIBITOR LP-149; Ac-NA-Val-Sta-Glu-NA-NH2 | Formula: | C46 H58 N6 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000429 | Name: | (ACE)APQV(STA)VMHP peptide Inhibitor | Formula: | C49 H81 N12 O13 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000430 | Name: | H 189 | Formula: | C62 H97 N17 O12 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000431 | Name: | CASPASE-7 INHIBITOR AC-DMQD-CHO | Formula: | C20 H33 N5 O10 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000434 | Name: | benzyl [(1S,4S,7S,8R,9R,10S,13S,16S)-7,10-dibenzyl-8,9-dihydroxy-1,16-dimethyl-4,13-bis(1-methylethyl)-2,5,12,15,18-pentaoxo-20-phenyl-19-oxa-3,6,11,14,17-pentaazaicos-1-yl]carbamate | Formula: | C50 H64 N6 O10 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000439 | Name: | ethyl (5S,8S,14S)-14-hydroxy-5,8,11-tris(2-methylpropyl)-3,6,9,12-tetraoxo-1-phenyl-2-oxa-4,7,10,11-tetraazapentadecan-15-oate | Formula: | C30 H48 N4 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000453 | Name: | N-[3-(1H-benzimidazol-1-yl)propanoyl]glycyl-L-alanyl-L-alaninamide | Formula: | C18 H24 N6 O4 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000457 | Name: | INHIBITOR CH2-QLTSNV-Z (SUBSTRATE-ANALOG) | Formula: | C36 H55 Cl N8 O12 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000465 | Name: | Argifin | Formula: | C29 H41 N9 O10 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000480 | Name: | DECAPEPTIDE HIRUDIN ANALOGUE | Formula: | C68 H95 N11 O26 S | Description: | DECAPEPTIDE | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000481 | Name: | N-terminal Asp des-amino Hirudin-3A' | Formula: | C64 H89 N11 O24 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000482 | Name: | YM-254890 | Formula: | C46 H69 N7 O15 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000483 | Name: | Bacillomycin Lc | Formula: | C47 H74 N10 O16 | Description: | BACILLOMYCIN LC IS A CYCLIC HEPTA-LIPOPETIDE
WITH 7 AMINO-ACIDS OF CONFIGURATION LDDLLDL AND
ONE D-BETA-AMINO CARBOXYLIC ACID.
THE FATTY ACID IS LINKED VIA A PEPTID BOND
TO BOTH RESIDUES 2 AND 8. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000484 | Name: | Balhimycin | Formula: | C66 H75 Cl2 N9 O25 | Description: | BALHIMYCIN IS A TRICYCLIC HEPTAPEPTIDE GLYCOSYLATED BY D-GLUCOSE (RESIDUE 8) ON RESIDUE 4 AND BY 4-OXO-VANCOSAMINE
(RESIDUE 9) ON RESIDUE 6. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000485 | Name: | Deglucobalhimycin | Formula: | C60 H65 Cl2 N9 O20 | Description: | DEGLUCOBALHIMYCIN LACKS THE D-GLUCOSE COMPONENT OF BALHIMYCIN CONSISTING OF THE TRICYCLIC HEPTAPEPTIDE AND
(2R,4S,6S)-4-AZANYL-4,6-DIMETHYL-OXANE-2,5,5-TRIOL ONLY LINKED TO RESIDUE 6. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000487 | Name: | Tsushimycin | Formula: | C59 H93 N13 O20 | Description: | TSUSHIMYCIN IS A CYCLIC LIPOPEPTIDE.
THE SCAFFOLD IS MADE OF TWO PARTS:
(1) ASP1 N-TERM EXOCYCLIC PART
(2) A DECAPEPTIDE RING. RESIDUE 2 AND 11 FORM
A PEPTIDE BOND.
A TETRADECENOIC FATTY ACID IS LINKED TO THE
RESIDUE 1 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000488 | Name: | TRIOSTIN A | Formula: | C50 H62 N12 O12 S2 | Description: | TRIOSTIN IS A BICYCLIC OCTADEPSIPEPTIDE.
BICYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI, AND A DISULPHIDE BOND BETWEEN
RESIDUES 3 AND 7.
THE TWO QUINOXALINE CHROMOPHORES ARE LINKED
TO THE D-SERINE RESIDUES, RESIDUES 1 AND 5. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000491 | Name: | Echinomycin | Formula: | C51 H64 N12 O12 S2 | Description: | ECHINOMYCIN IS A BICYCLIC OCTADEPSIPEPTIDE.
BICYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI, AND A THIOACETAL BOND BETWEEN
RESIDUES 3 AND 7.
THE TWO QUINOXALINE CHROMOPHORES ARE LINKED
TO THE D-SERINE RESIDUES, RESIDUES 1 AND 5. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000492 | Name: | uk63052 | Formula: | C56 H68 N10 O14 S2 | Description: | QUINOMYCIN UK63052 IS A BICYCLIC OCTADEPSIPEPTIDE.
BICYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI, AND A THIOACETAL BOND BETWEEN
RESIDUES 3 AND 7.
THE TWO HYDROXYQUINOXALINE CHROMOPHORES ARE LINKED
TO THE D-SERINE RESIDUES, RESIDUES 1 AND 5. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000503 | Name: | ADEP1 | Formula: | C38 H50 N6 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000504 | Name: | ADEP2 | Formula: | C41 H56 F2 N6 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000505 | Name: | Quinupristin | Formula: | C53 H67 N9 O10 S | Description: | QUINUPRISTIN IS A CYLIC HEPTAPEPTIDE. THE RING GENERATED BY LINKING RESIDUE 2 SIDE-CHAIN IS AND MAIN-CHAIN RESIDUE 7. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000507 | Name: | PYOVERDIN C-E CHROMOPHORE | Formula: | C55 H86 N17 O22 | Description: | IN IRON-DEFICIENT CONDITIONS, PSEUDOMONAS AERUGINOSA SECRETES A MAJOR FLUORESCENT SIDEROPHORE NAMED PYOVERDIN (PVD),
WHICH AFTER CHELATING IRON(III) IS TRANSPORTED BACK INTO THE CELL VIA ITS OUTER MEMBRANE RECEPTOR FPVA. FPVA IS A
TONB-DEPENDENT TRANSPORT PROTEIN AND HAS THE ABILITY TO BIND PVD IN ITS APO- OR IRON-LOADED FORM. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000556 | Name: | AERUGINOSIN 98-B | Formula: | C29 H46 N6 O9 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000557 | Name: | Pepstatin | Formula: | C34 H63 N5 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|